Home > USA > Investors > 2009 ASX Announcements
 
 
 
HomeAbout UsProducts & TechnologyCliniciansPatients & FamiliesMedia CentreInvestor Centre
 
 
Investor Centre
 
Welcome'width='178
Corporate Profile
Investor Fact Sheet
Share Price Information
ASX Announcements
SEC Filings
News Releases
Annual Reports
Corporate Presentations
Events Calendar
Corporate Governance
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations
 
 
 
 
 
 2009 ASX Announcements
 
 

Email Alerts Receive Email Alerts | RSS RSS Feeds
Keyword Search
 
2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
12/10/09Exercise of Options - Appendix 3BPrinter Friendly Version
12/08/09Change of Director's Interest NoticePrinter Friendly Version
12/02/09Exercise of Expiring Incentive OptionsPrinter Friendly Version
11/24/09HeartWare files IDE for Destination TherapyPrinter Friendly Version
11/23/09Change of Director's Interest NoticePrinter Friendly Version
11/23/09Exercise of (Expiring) OptionsPrinter Friendly Version
11/17/09Change of Director`s Interest NoticesPrinter Friendly Version
11/17/09Exercise of Options - ASX Appendix 3BPrinter Friendly Version
11/10/09Change of Contact Details for HeartWarePrinter Friendly Version
11/09/09CEO Presenting at Investment ConferencesPrinter Friendly Version
11/06/09HeartWare to Present at Upcoming Investment Conferences in NovemberPrinter Friendly Version
11/05/09Revenues of US$7.5M for Quarter Ended 30 September 2009Printer Friendly Version
11/05/09Financial Statements for September 30, 2009Printer Friendly Version
10/29/09Advance Notice of Q3 Earnings CallPrinter Friendly Version
10/27/09Capital Raising Allotment - ASX Appendix 3BPrinter Friendly Version
10/27/09Stockholder Meeting Results - Capital Raising ApprovedPrinter Friendly Version
10/27/09Cleansing Notice for Capital RaisingPrinter Friendly Version
10/06/09FDA Approves Expansion to 40 Sites for US BTT TrialPrinter Friendly Version
10/05/09Exercise of Incentive OptionsPrinter Friendly Version
09/23/09Notice of Special Meeting of Stockholders - Capital RaisingPrinter Friendly Version
09/21/09Annual Employee Equity AllocationPrinter Friendly Version
09/21/09Exercise and Cancellation of OptionsPrinter Friendly Version
09/07/09Option Exercise and CancellationsPrinter Friendly Version
09/02/09Reinstatement to Official QuotationPrinter Friendly Version
09/02/09Half Yearly Report / Accounts and Review ReportPrinter Friendly Version
08/21/09HeartWare Surpasses 50 US ImplantsPrinter Friendly Version
08/18/09Cleansing Notice for US$60 Miliion PlacementPrinter Friendly Version
08/18/09Closes US$60 Million PlacementPrinter Friendly Version
08/17/09ASX Appendix 4D And Half Year Financial Statements (US GAAP)Printer Friendly Version
08/11/09US$55 Million Capital RaisingPrinter Friendly Version
08/03/09Joint Termination of MergerPrinter Friendly Version
07/31/09Change of Directors Interests - Annual Meeting Stock IssuePrinter Friendly Version
07/31/09Issue of Stock Pursuant to Annual Meeting ApprovalPrinter Friendly Version
07/31/09Quarterly Update And ASX Appendix 4CPrinter Friendly Version
07/30/09Annual Meeting ResultsPrinter Friendly Version
07/30/09US FTC to Challenge Thoratec Acquisition of HeartWarePrinter Friendly Version
07/30/09Trading HaltPrinter Friendly Version
07/30/09Annual Meeting MaterialsPrinter Friendly Version
07/29/09Annual Meeting to be WebcastPrinter Friendly Version
07/21/09Change of Interests in Securities for Executive DirectorPrinter Friendly Version
07/06/09Appendix 3B - Vesting of RSUsPrinter Friendly Version
07/02/09Appendix 3BPrinter Friendly Version
06/18/09Appendix 3BPrinter Friendly Version
06/17/09Revised Thoratec Merger DocumentationPrinter Friendly Version
06/12/09Notice of Annual General Meeting/Proxy FormPrinter Friendly Version
05/12/09CEO Presenting at JMP Securities Research ConferencePrinter Friendly Version
05/12/09Quarterly Financial Statements 31 March 2009Printer Friendly Version
05/11/09Thoratec Files Registration StatementPrinter Friendly Version
05/08/09Thoratec Files Registration StatementPrinter Friendly Version
04/30/09Quarterly Update April 2009 and ASX Appendix 4CPrinter Friendly Version
04/24/09European Clinical Data UpdatePrinter Friendly Version
03/31/09First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment UpdatePrinter Friendly Version
03/27/09Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade CommissionPrinter Friendly Version
03/18/09Appendix 3BPrinter Friendly Version
02/27/092008 Annual Financial ReportPrinter Friendly Version
02/27/092008 Preliminary Final ReportPrinter Friendly Version
02/20/09NASDAQ Listing ConfirmationPrinter Friendly Version
02/19/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/18/09Additional Merger DocumentationPrinter Friendly Version
02/16/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/13/09Trading HaltPrinter Friendly Version
02/10/09First Implants at Northwestern MemorialPrinter Friendly Version
02/06/09Co-PI Appointed for US Clinical TrialPrinter Friendly Version
01/30/09Quarterly Report and CEO LetterPrinter Friendly Version
01/30/09CE Mark Approval receivedPrinter Friendly Version
01/13/09J P Morgan Healthcare Conference PresentationPrinter Friendly Version

 
 
Copyright © HeartWare International, Inc.